AMP Health vs Hims
AMP Health and Hims both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hims
Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC
Visit Hims →If you are choosing between AMP Health and Hims, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Hims leads our six-part score, 6.8 to 6.4. Both have drawn an FDA warning letter.
AMP Health vs Hims price
AMP Health and Hims start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide is cheaper at Hims ($299 a month vs $309 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, AMP Health prices compounded injections, while Hims prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hims is the only one of the two with a brand-name price.
Where each one treats patients
AMP Health does not publish where it ships, and Hims lists 50 states.
Pricing
AMP Health
Plus $79/mo subscription
Plus $79/mo subscription
Plus $79/mo subscription
Hims
Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)
What each price covers
Hims' price also covers the medication itself, which AMP Health does not claim.
AMP Health does not say what its price includes.
Hims is silent on shipping and lab work.
That matters most for the drug: unless AMP Health confirms otherwise, budget for medication on top of its listed price.
AMP Health
Inclusions not disclosed.
Hims
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall, Hims scores 6.8 and AMP Health 6.4 out of 10.
AMP Health is stronger on value (4.5 vs 3.0) and support (5.0 vs 3.0).
Hims is stronger on trust & safety (7.0 vs 3.5) and accessibility (10.0 vs 5.0).
Effectiveness and user experience are within half a point.
AMP Health
6.4/10
Hims
6.8/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent AMP Health a warning letter dated February 20, 2026 (letter 717992), and it is still open.
The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.
Features & Coverage
| Feature | AMP Health | Hims |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | ✓4 features | 2 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | 1 letter | 1 letter |
About AMP Health
AMP Health sells compounded semaglutide, injectable and oral, from $199/mo and tirzepatide from $309/mo, on top of a $79/mo subscription fee. Brand Wegovy is listed but out of stock. There is a 30-day satisfaction guarantee.
Read our full AMP Health review →About Hims
Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.
Read our full Hims review →Pros & Cons
AMP Health
What we like
- Semaglutide costs $199 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
Watch-outs
- Tirzepatide costs $309 a month, 24% above the $250 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued AMP Health a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hims
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- Names 4 pharmacies that fill its prescriptions, which most sellers do not
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Hims wins this one, 6.8 to 6.4, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. AMP Health fits better if an oral route if you will not self-inject is your priority.
Choose AMP Health if…
You want an oral route if you will not self-inject and an opening price near $199 a month.
Choose Hims if…
You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →AMP Health vs Hims: FAQ
Close alternatives to AMP Health and Hims
- AMP Health vs Hers
- AMP Health vs Curex
- AMP Health vs HumeCare+
- Hims vs Hers
- Hims vs Care Bare Rx
- Hims vs Concierge MD LA
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.